XML 29 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2024
Mar. 31, 2023
Current assets:    
Cash and cash equivalents $ 1,923.0 $ 1,554.0
Short-term investments 1,000.0 661.0
Accounts receivable, net (including receivables from related parties of $182 and $402 as of March 31, 2024 and 2023, respectively) 781.0 999.0
Contract assets (including contract assets from related parties of $22 and $9 as of March 31, 2024 and 2023, respectively) 336.0 154.0
Prepaid expenses and other current assets 157.0 169.0
Total current assets 4,197.0 3,537.0
Non-current assets:    
Property and equipment, net 215.0 185.0
Operating lease right-of-use assets 205.0 206.0
Equity investments (including investments held at fair value of $573 and $592 as of March 31, 2024 and 2023, respectively) 741.0 723.0
Goodwill 1,625.0 1,620.0
Intangible assets, net 152.0 138.0
Deferred tax assets 282.0 139.0
Non-current portion of contract assets 240.0 116.0
Other non-current assets 270.0 202.0
Total non-current assets 3,730.0 3,329.0
Total assets 7,927.0 6,866.0
Current liabilities:    
Accrued compensation and benefits and share-based compensation 298.0 589.0
Tax liabilities 147.0 162.0
Contract liabilities (including contract liabilities from related parties of $107 and $135 as of March 31, 2024 and 2023, respectively) 198.0 293.0
Operating lease liabilities 27.0 26.0
Other current liabilities (including payables to related parties of $7 and $17 as of March 31, 2024 and 2023, respectively) 835.0 293.0
Total current liabilities 1,505.0 1,363.0
Non-current liabilities:    
Non-current portion of accrued compensation and share-based compensation 20.0 152.0
Deferred tax liabilities 135.0 262.0
Non-current portion of contract liabilities 717.0 807.0
Non-current portion of operating lease liabilities 194.0 193.0
Other non-current liabilities 61.0 38.0
Total non-current liabilities 1,127.0 1,452.0
Liabilities 2,632.0 2,815.0
Commitments and contingencies (Note 19)
Shareholders’ equity:    
Ordinary shares, $0.001 par value; 1,088,334,144 shares authorized and 1,040,330,497 shares issued and outstanding as of March 31, 2024; and 1,025,234,000 shares authorized, issued and outstanding as of March 31, 2023 2.0 2.0
Additional paid-in capital 2,171.0 1,216.0
Accumulated other comprehensive income 371.0 376.0
Retained earnings 2,751.0 2,457.0
Total shareholders’ equity 5,295.0 4,051.0
Total liabilities and shareholders’ equity $ 7,927.0 $ 6,866.0